-
del Pozo-Rodríguez A, Delgado D, Solinís MA, Pedraz JL, Echevarría E, Rodríguez JM, Gascón AR.
Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration
International Journal of Pharmaceutics,
2010;
385,
157 - 162
-
Ochoa L, Igartua M, Hernández RM, Solinís MA, Gascón AR, Pedraz JL.
In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro–in vivo correlation
European Journal of Pharmaceutics and Biopharmaceutics,
2010;
75,
232 - 237
-
Zuñiga L, Calvo B.
Biosimilars: pharmacovigilance and risk management
Pharmacoepidemiology and Drug Safety,
2010;
19,
661 - 669
-
Zuñiga L, Calvo B.
Biosimilars approval process
Regulatory Toxicology and Pharmacology,
2010;
56
-
Calvo B, Zuñiga L.
Regulatory basis of biosimilar medicinal products: Need for harmonization
Pharmaceuticals Policy and Law,
2010;
12,
205 - 215
-
Calvo B, Zuñiga L.
Medicamentos biotecnológicos: Biosimilares. Requisitos exigidos para su desarrollo y aprobación
Información Tecnológica,
2010;
21,
125 - 132
